Semaglutide vs Tirzepatide: Ozempic-style or Mounjaro-style for weight and diabetes?
The short answer
Both are weekly injections that transformed diabetes and weight treatment. Tirzepatide (Mounjaro) produced the larger average weight loss in head-to-head-adjacent trials; semaglutide (Ozempic, Wegovy, oral Rybelsus) has the longer record, an oral option, and proven heart protection. In Nigeria the deciding factors are usually availability, price — and above all, avoiding the flood of counterfeit pens.
Semaglutide mimics one gut hormone (GLP-1); tirzepatide mimics two (GLP-1 and GIP). Both quiet appetite, slow stomach emptying, and improve blood sugar; in trials, average weight loss on high-dose tirzepatide exceeded semaglutide's, though individual responses vary widely and both are genuinely effective. Both demand gradual dose escalation to tame nausea, and both regain their ground if stopped without lifestyle change — these are treatments, not cures.
The Nigerian reality check: demand has raced ahead of legitimate supply, prices run to hundreds of thousands of naira monthly, and counterfeit 'Ozempic' pens are an active, documented danger. Buy only from licensed pharmacies, verify NAFDAC registration, and involve a doctor — these drugs have real contraindications (pancreatitis history, certain thyroid cancers, pregnancy) and deserve medical supervision, not Instagram sourcing.
Side by side
| Semaglutide | Tirzepatide | |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GIP + GLP-1 agonist |
| Average weight loss in trials | Substantial | Larger on average at top doses |
| Formats | Weekly pen; daily oral tablet exists (Rybelsus) | Weekly pen only |
| Proven heart benefit | Yes — established cardiovascular outcome data | Strong metabolic data; outcome evidence still maturing |
| Counterfeit risk in Nigeria | High — verify every pen | High — verify every pen |
| Drug class | GLP-1 receptor agonist | GIP and GLP-1 receptor agonist (dual) |
| Typical price | ₦350,000–₦600,000 per Ozempic pen (about 1 month) | ₦600,000–₦980,000 per pen (about 1 month) |
| NAFDAC registrations | 0 active Greenbook listings | 0 active Greenbook listings |
| Common brands | Ozempic, Rybelsus | Mounjaro, Zepbound |
Prices are sampled from licensed Nigerian online pharmacies and span brands and pack sizes — indicative only. Registration counts are from our copy of the NAFDAC Greenbook (July 2026); listings can lag renewals.
Reach for Semaglutide when…
- •Cardiovascular protection is a priority alongside sugar/weight
- •You want the oral-tablet option
- •Your doctor prefers the longest-established agent
Reach for Tirzepatide when…
- •Maximum average weight loss is the primary goal
- •Semaglutide plateaued for you under medical supervision
- •Availability/pricing locally happens to favour it
Frequently asked questions
Educational comparison, not a prescription. Both medicines have full guides covering dosage, side effects, and warnings — talk to a pharmacist or doctor before switching. Updated July 2026.